Jeffrey Matthew Rose - 26 May 2026 Form 4 Insider Report for MEDIFAST INC (MED)

Reporting relationship: Director
Issuer ticker: MED
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 19:34:17 UTC
Prior SEC filing: 28 May 2026
Source filing: View source filing
Reporting owner signature: /s/ James P. Maloney, attorney-in-fact

Key filing fact

Jeffrey Matthew Rose filed Form 4 for MEDIFAST INC (MED) on 28 May 2026.

Key facts

This page summarizes Jeffrey Matthew Rose's Form 4 filing for MEDIFAST INC (MED).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 28 May 2026, 19:34.

Change

Previous filing in this sequence was filed on 28 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002137123 Primary reporting owner

Rose Jeffrey Matthew

Relationship: Director
Address: C/O MEDIFAST, INC., 1501 S. CLINTON STREET, SUITE 500, BALTIMORE
Signature: /s/ James P. Maloney, attorney-in-fact
Signature date: 28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MED transaction

Common Stock

Award

Transaction value
Shares: +11,680
Change %
Price: $0.000000^*
Shares after: 11,680
Date: 26 May 2026
Ownership: Direct
Footnotes: F1

MED transaction

Common Stock

Award

Transaction value
Shares: +6,739
Change %: +58%
Price: $0.000000^*
Shares after: 18,419
Date: 26 May 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027.

Footnote F2

The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.